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Obsessive–compulsive disorder (OCD) is achronic psychiatric disorder characterized by
recurrent intrusive thoughts and/or repetitive compulsory behaviors. This psychiatric disor-
der is known to be stress responsive, as symptoms increase during periods of stress
but also because stressful events may precede the onset of OCD. However, only a
few and inconsistent reports have been published about the stress perception and the
stress-response in these patients. Herein, we have characterized the correlations of OCD
symptoms with basal serum cortisol levels and scores in a stress perceived question-
naire (PSS-10). The present data reveals that cortisol levels and the stress scores in the
PSS-10 were significantly higher in OCD patients that in controls. Moreover, stress levels
self-reported by patients using the PSS-10 correlated positively with OCD severity in the
Yale–Brown Obsessive–Compulsive Scale (Y–BOCS). Interestingly, PSS-10 scores corre-
lated with the obsessive component, but not with the compulsive component, ofY–BOCS.
These results confirm that stress is relevant in the context of OCD, particularly for the
obsessive symptomatology.
Keywords: obsessive–compulsive disorder, stress, cortisol,Y–BOCS, PSS-10
INTRODUCTION
Obsessive–compulsive disorder (OCD) is a psychiatric disorder
that affects 2–3% of population worldwide (Ruscio et al., 2010)
and carries high levels of morbidity (Murray and Lopez, 1996;
Hollander et al., 2010). It is characterized by obsessions (persis-
tent, intrusive, and inappropriate thoughts, as well as impulses or
images that cause anxiety) and compulsions (repetitive behaviors
or thoughts performed in order to decrease the anxiety caused by
the obsessions). Although genetic factors play an important role
in the etiology of disease, several reports implicate environmental
influences such as relevant life events and traumatic events in the
onset of the disease (Zohar et al., 2007; Forray et al., 2010). Ana-
lyzing a group of 74 female OCD patients, Lochner et al. (2002)
found them to have higher rates of childhood trauma than healthy
controls. Interestingly, subsequent studies demonstrated that fre-
quency, clinical pattern, and severity of OCD symptoms correlated
not only with a history of one or more traumatic life events (Ger-
shuny et al., 2003; Cromer et al., 2007; Real et al., 2011) but also
with their intensity (Jordan et al., 1991).
Importantly, the stress-response and the activity of the
hypothalamic-pituitary-adrenal (HPA) axis have been shown to
be relevant in the context of several psychiatric disorders (Hols-
boer, 1983). This also holds true for OCD as it is known that
stressful events may precede the onset of OCD (Toro et al., 1992)
and that, in addition, OCD symptoms increase at times of stress
(Findley et al., 2003). Nevertheless, it is also true that core symp-
toms of the disease, namely obsessions, cause significant distress,
and as a consequence, may trigger physiological stress-related sys-
tems such as the HPA axis. However, the characterization of the
activity of the HPA axis in OCD is still a matter of dispute, with
some studies reporting normal levels of cortisol (Kulog˘lu et al.,
2007) and a normal dexamethasone suppression response (Mon-
teiro et al., 1986; Jenike et al., 1987), while others observe high
levels of cortisol (Gehris et al., 1990; Kluge et al., 2007) and non-
suppression of cortisol during suppression tests (Cottraux et al.,
1984; Catapano et al., 1990). Yet, the discrepancies extend beyond
the measurement of cortisol levels; in fact, while one study showed
increased corticotrophin releasing hormone (CRH) levels in the
cerebrospinal fluid (Altemus et al., 1992) of OCD patients, which
might be indicative of hyperactivation of stress-response systems,
another found a decreased pituitary volume in OCD patients
(Jung et al., 2009), which is suggestive of hypofunction of the
adenohypophysis.
In light of such controversy, we thought of interest to further
characterize the link between OCD and stress. In order to achieve
this aim, we measured basal serum cortisol levels and assessed
the perception of stress using a validated perceived stress scale 10
(PSS-10) in a group of OCD patients (without depression) and
in a cohort of age- and sex-matched controls. In patients, such
measurements were subsequently correlated with OCD symp-
toms, namely by discriminating the obsessive and compulsive
components using the Yale–Brown Obsessive–Compulsive Scale
(Y–BOCS).
MATERIALS AND METHODS
PARTICIPANTS
The cohort under analysis comprised 18 patients with OCD and
18 healthy controls. Patients were admitted to the Psychiatric
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Department of Hospital de Braga as outpatients with a diagnosis
of OCD. All patients were aged>18 years and able to communicate
in Portuguese. Diagnosis was established by experienced psychi-
atrists with a semi-structured interview based on Diagnostic and
Statistical Manual of Mental Disorders, Fourth Edition (DSM-
IV)-TR and corroborated by a severity score of 7 or greater on
the Y–BOCS. Exclusion criteria included: any other mental disor-
der revealed by the Mini-International Neuropsychiatric Interview
(MINI Plus; except for OCD), any acute and/or chronic medical
illness as assessed by a physical examination and routine laboratory
examination, females who are pregnant or lactating and substance
dependence within the previous 12 months. From 21 patients ini-
tially enrolled, 3 dropped out and thus only 18 were analyzed (2
patients were not included because they did not attend for blood
collection and in the remainder case, blood sample was not col-
lected properly). The three matching controls were also excluded
from the analysis.
Healthy controls were carefully recruited to match OCD
patients for age, sex, educational level, ethnical origin, and dom-
inance. Exclusion criteria included previous history of neuropsy-
chiatric disorder, any present mental disorder revealed by MINI
Plus and use of any medication (excluding oral contraceptives).
All subjects provided written informed consent following a
description of the procedures. The study protocol was approved by
the Ethics Committee of the Hospital of Braga, Portugal. The study
was performed in accordance with the Declaration of Helsinki.
INSTRUMENTS
Sociodemographic form
All subjects were evaluated by a semi-structured questionnaire
form in order to characterize gender, age, marital status, edu-
cational level, professional status, ethnical origin, and previous
medical history of the cohorts. OCD patients were also evaluated
in terms of duration of illness, type of obsessions, and compulsions
and medication taken. Table 1 summarizes the characteristics of
patients and healthy controls.
Mini-international neuropsychiatric interview
Patients were assessed with MINI Plus, a short structured diag-
nostic interview (Sheehan et al., 1998), design to screen for
neuropsychiatric diagnosis according to the DSM-IV.
Yale–Brown obsessive–compulsive scale
Yale–Brown Obsessive–Compulsive Scale was used to assess
the severity of OCD and to discriminate the symptoms sub-
components of the disorder. The Y–BOCS is composed of 10-
items, half related with obsessions and the other half related with
compulsions. Each item is assessed by a clinician and rated on a
five-point likert-type scale from 0 to 4 (Goodman et al., 1989).
Perceived stress scale 10
The Portuguese version of the 10-items Perceived Stress Scale,
filled-out on the same day of blood collection, was used to assess
perception of stress (Cohen et al., 1983). Items were classified on
a five-point likert-type scale from 0 (never) to 4 (very often), and
refer to the last month. The higher the total score, the greater the
intensity of stress perceived by the subject.
Hamilton depression rating scale
This 17-items scale is used to rate the severity of depression
(Hamilton, 1960). Scores higher than 25 indicate severe depression
while scores below 7 indicate no depression.
Hamilton anxiety rating scale
Fourteen-items scale used to evaluate severity of anxiety (Hamil-
ton, 1959). Each item is scored on a scale of 0 (not present) to 4
(severe). Scores higher than 25 indicate moderate/severe anxiety
while scores below 17 indicate mild symptoms.
Blood sampling
Venous blood samples from left forearm vein were collected into
5 mL tubes containing potassium EDTA, between 1:00 and 4:00
p.m. Precise instructions about sleep and alimentation were given
to volunteers that should not have any food neither drink except
water in the 6-h prior the blood collection. Plasma was sepa-
rated by centrifugation and stored at −70˚C. Serum cortisol was
determined by standard radioimmuno assays.
STATISTICAL ANALYSIS
Data was analyzed using SPSS (version 19.0; IBM). Demograph-
ics, clinical measures, psychometric scales, and laboratory values
were reported using descriptive statistics (frequencies, means, and
standard deviation). Group comparisons were carried out by non-
parametric Mann–WhitneyU test to compare means. For correla-
tion evaluations, the Pearson correlation test was used. Differences
were considered to be significant if p< 0.05.
RESULTS
No significant differences in age, gender, education, or body mass
index were found between the OCD group and controls (Table 1).
Three OCD patients and four healthy controls were taking oral
contraceptives, but no major differences/trends were observed
between those on and without them.
The mean OCD severity was 25.61 as measured by Y–BOCS;
there was no significant difference between the obsessive and
the compulsive sub-scores in OCD patients (Table 1). The mean
depression score [measured by Hamilton Depression Rating Scale
(HDRS)] was 3.83; importantly, no subject displayed values above
7. The mean anxiety score [measured by Hamilton Anxiety Rat-
ing Scale (HARS)] was 4.33. The mean age of onset of the disease
was 21.61 years and mean duration of illness was 5.72 years. All
patients were medicated at the time of study, 77.8% with fluvox-
amine alone (200–300 mg/day) and 22.2% with fluvoxamine and
clomipramine (200–300 and 75–150 mg/day, respectively). The
clinical characteristics of patients are summarized in Table 1.
The basal serum concentration of cortisol was significantly
higher in OCD patients than in healthy controls (P = 0.011)
(Figure 1A). Stress perception, as assessed by PSS-10, was signifi-
cantly higher in OCD patients than in control subjects (P ≤ 0.001)
(Figure 1B). Importantly, we found a positive correlation between
these two measurements of response to stress in our entire popu-
lation (r = 0.385, P = 0.020) (Figure 1C) that was only replicated
in control subjects (r = 0.717, P = 0.001) (Figure 1D) but not in
OCD patients (r = 0.040, P = 0.874) (Figure 1E).
Stress self-reported by patients using PSS-10 positively cor-
related with OCD severity as assessed by Y–BOCS (r = 0.596,
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Table 1 | Sociodemographic and clinical characteristics of patients with obsessive–compulsive disorder and healthy comparison subjects.
Characteristics Subjects with
OCD (n=18)
Healthy comparison
subjects (n=18)
Statistics
Age, years [mean±SD (range)] 27.33±6.11 (21–38) 26.28±5.21 (20–38) P =0.691
Male/female 12/6 12/6
Education, years [mean±SD (range)] 13.22±1.99 (12–18) 14.06±3.37 (12–18) P =0.346
Body mass Index [mean±SD (range)] 23.70±4.18 (17–31) 22.78±2.18 (19–29) P =1.000
Age of onset [mean±SD (range)] 21.61±7.05 (9–35)
Duration of illness [mean±SD (range)] 5.72±6.70 (0–21)
Y–BOCS (total score) 25.61±5.90 (12–30)
Y–BOCS (obsession score) 13.50±3.17 (7–20)
Y–BOCS (compulsion score) 12.11±3.27 (5–17)
HDRS (global score) 3.83±2.53 (0–7)
HARS (global score) 4.33±3.20 (0–16)
Medication Only SSRI – 14 (77.8%);
SSRI with TCA – 4 (22.2%)
OCD, obsessive–compulsive disorder;Y–BOCS,Yale–Brown obsessive–compulsive scale; HDRS, Hamilton depression rating scale; SSRI, serotonin selective reuptake
inhibitors; TCA, tricyclic antidepressant; HARS, Hamilton anxiety rating scale.
FIGURE 1 | Stress response in OCD patients and controls. OCD
patients shown high basal levels of serum cortisol (12.98±5.77 mg/dL)
when compared with healthy controls (8.28± 3.60 mg/dL) (A). In
accordance, OCD patients score higher in the perceived stress scale
(PSS-10) questionnaire (B). Importantly, these two measurements were
positively correlated (C). Looking at each group separately, cortisol and
PSS-10 score correlate in healthy controls (D) but not in OCD patients (E)
*p< 0.05.
P = 0.009) (Figure 2A). Interestingly, no significant correlation
was found between cortisol levels and OCD severity as assessed
by Y–BOCS (r = 0.222, P = 0.376) (Figure 2B). Importantly, the
score on the PSS-10 correlated significantly with obsessive compo-
nent of Y–BOCS (r = 0.669, P = 0.002) (Figure 2C), but not with
the compulsive sub-score (r = 0.326, P = 0.187) (Figure 2D).
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FIGURE 2 | Obsessive–compulsive disorder severity and stress-related
measures. OCD severity, as measured by Y–BOCS, positively correlate with
PSS-10 score (A), but not with serum cortisol levels (B). Looking at each
dimension of the Y–BOCS scale separately, there is a positive correlation
between perceived stress and the obsessive score (C) but not with the
compulsive score (D) *p<0.05.
DISCUSSION
In this study, we show that OCD patients report significantly
higher levels of perceived stress than healthy controls, and that
these are accompanied with higher serum cortisol levels. These
findings support the hypothesis that dysregulated stress-response
mechanisms are of relevance to this disorder. In this regard, it is
important to note that, in our study, self-reported perceived stress
levels also correlated positively with global severity of OCD, fur-
ther strengthening the relevance of our data. Interestingly, these
results are in line with a study by Jordan et al. (1991) in which
previous traumatic events correlated with the intensity of OCD
symptoms. Our data also shows that perceived stress is significantly
correlated with the intensity of obsessive symptoms, but not with
the intensity of compulsions. Indeed, while obsessions are highly
stressful and anxiogenic ideas, compulsive actions are usually per-
ceived as stress relieving. Of note, this finding is in accordance with
previous studies that reports that OCD patients suffer significantly
more stress by daily events (Coles et al., 2005) and that there is an
important relationship between distress tolerance and obsessions
(Cougle et al., 2011).
Although self-reported stress was highly correlated with illness
severity and obsessive component of Y–BOCS, this study fails to
demonstrate correlations between cortisol levels and OCD global
severity or each OCD specific component. These can be explained
by the recruitment of alternative systems of stress-response but
also by the dynamic balance between obsessions and compulsions.
High levels of cortisol were reported in previous studies (Gehris
et al., 1990; Kluge et al., 2007), even though one study has observed
that cortisol elevation was only related with co-morbid depres-
sive symptoms (Kulog˘lu et al., 2007). Despite these inconsistent
reports, several findings such as non-suppression on dexametha-
sone test (Cottraux et al., 1984; Catapano et al., 1990), elevation
of nocturnal ACTH (Kluge et al., 2007), and reduced pituitary
volumes in non-treated OCD patients (Jung et al., 2009) support
the altered functioning of HPA axis. Additionally, results from
a study that analyzes therapeutic effects and hormonal changes
induced by intravenous citalopram treatment suggest that the drug
effects are dependent on cortisol response to SSRI (Corregiari et al.,
2007) which can be related with cortisol modulation of 5-HT1A
post-synaptic activity (Karten et al., 1999; Bijak et al., 2001). Inter-
estingly,we report significant elevations of cortisol levels in a group
of OCD patients that are receiving treatment for more than 6 weeks
but remain with significant symptoms of disease.
The stress-related findings pointed out by this work are not
specific of OCD and can be found in other psychiatric disorders
such as depression. However, dysfunction in orbitofronto-striatal
circuits has been the most common finding in the pathophys-
iology of OCD and previous animal and human studies have
shown that these circuits are highly sensitive and can be disrupted
by chronic stress, inducing a shift in observed decision-making
behaviors through habits (Dias-Ferreira et al., 2009; Soares et al.,
2012) and impairing ability of associate environmental cues to
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goal-directed behaviors (Morgado et al., 2012). Altogether, these
observations support a possible role for chronic stress in the
etiology of OCD.
By using a significantly homogeneous group of patients that did
not display any comorbidity, we eliminate some frequent biases
observed in other studies. However, this study has some method-
ological limitations that should be taken into account: first, we
included only medicated patients with OCD, which might bias
results; second, this study has a cross-sectional design; and finally,
the size of the sample is relatively small.
In summary, this work highlights the dysfunction of stress
perception and stress-response systems in the OCD. However,
more studies are necessary to clarify whether these findings are
implicated in the onset of the symptomatology or are a mere
consequence of the symptoms.
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